Want to see HK:3662 full AI Analyst Report?
Aoyuan Healthy Life Group Co. Ltd. (3662) Ratios
Aoyuan Healthy Life Group Co. Ltd. Ratios
HK:3662's free cash flow for Q2 2026 was $-37.83M. For the 2026 fiscal year, HK:3662's free cash flow was decreased by $-4.11M and operating cash flow was $-33.72M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.81 | 1.68 | 1.60 | 1.40 | 1.20 |
| Quick Ratio | 1.81 | 1.67 | 1.59 | 1.39 | 1.20 |
| Cash Ratio | 1.04 | 0.94 | 0.89 | 0.72 | 0.83 |
| Solvency Ratio | 0.07 | 0.11 | 0.16 | 0.16 | -0.11 |
| Operating Cash Flow Ratio | 0.04 | 0.13 | 0.10 | -0.09 | -0.06 |
| Short-Term Operating Cash Flow Coverage | 1.09 | 2.00 | 1.01 | -0.76 | -0.22 |
| Net Current Asset Value | $ 758.70M | $ 720.95M | $ 634.23M | $ 438.38M | $ 249.01M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.05 | 0.07 | 0.18 |
| Debt-to-Equity Ratio | 0.05 | 0.07 | 0.10 | 0.17 | 0.55 |
| Debt-to-Capital Ratio | 0.05 | 0.06 | 0.09 | 0.15 | 0.36 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.85 | 1.96 | 2.07 | 2.38 | 3.07 |
| Debt Service Coverage Ratio | 2.47 | 1.80 | 1.36 | 1.35 | -0.32 |
| Interest Coverage Ratio | 22.73 | 23.77 | 22.04 | 8.75 | -0.50 |
| Debt to Market Cap | 0.12 | 0.22 | 0.34 | 0.12 | 0.27 |
| Interest Debt Per Share | 0.10 | 0.12 | 0.17 | 0.24 | 0.61 |
| Net Debt to EBITDA | -7.75 | -5.89 | -4.38 | -2.85 | 7.31 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.62% | 28.41% | 25.57% | 24.37% | 24.18% |
| EBIT Margin | 8.17% | 10.24% | 11.29% | 13.18% | -7.34% |
| EBITDA Margin | 9.96% | 11.88% | 12.70% | 15.05% | -5.61% |
| Operating Profit Margin | 8.17% | 10.24% | 11.29% | 8.20% | -0.82% |
| Pretax Profit Margin | 5.94% | 8.14% | 12.45% | 12.25% | -8.98% |
| Net Profit Margin | 4.23% | 7.10% | 10.05% | 9.84% | -9.83% |
| Continuous Operations Profit Margin | 3.96% | 6.36% | 9.55% | 10.01% | -10.16% |
| Net Income Per EBT | 71.19% | 87.19% | 80.76% | 80.37% | 109.56% |
| EBT Per EBIT | 72.65% | 79.51% | 110.31% | 149.31% | 1097.93% |
| Return on Assets (ROA) | 2.31% | 4.08% | 6.89% | 7.22% | -8.33% |
| Return on Equity (ROE) | 4.28% | 8.00% | 14.27% | 17.22% | -25.55% |
| Return on Capital Employed (ROCE) | 7.93% | 10.97% | 14.99% | 12.98% | -1.88% |
| Return on Invested Capital (ROIC) | 5.09% | 8.10% | 10.52% | 9.32% | -1.29% |
| Return on Tangible Assets | 2.46% | 4.37% | 7.48% | 8.06% | -9.31% |
| Earnings Yield | 18.17% | 29.70% | 50.27% | 13.45% | -13.23% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.69 | 2.25 | 2.66 | 2.94 | 5.13 |
| Payables Turnover | 3.46 | 3.31 | 4.31 | 4.52 | 6.14 |
| Inventory Turnover | 323.66 | 81.88 | 91.67 | 133.85 | 422.79 |
| Fixed Asset Turnover | 19.48 | 33.84 | 34.28 | 33.56 | 30.74 |
| Asset Turnover | 0.55 | 0.57 | 0.69 | 0.73 | 0.85 |
| Working Capital Turnover Ratio | 1.60 | 1.93 | 2.75 | 4.22 | 4.32 |
| Cash Conversion Cycle | 111.91 | 56.33 | 56.37 | 45.99 | 12.54 |
| Days of Sales Outstanding | 216.23 | 162.29 | 137.08 | 124.09 | 71.15 |
| Days of Inventory Outstanding | 1.13 | 4.46 | 3.98 | 2.73 | 0.86 |
| Days of Payables Outstanding | 105.45 | 110.42 | 84.69 | 80.83 | 59.48 |
| Operating Cycle | 217.36 | 166.74 | 141.06 | 126.82 | 72.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.05 | 0.19 | 0.15 | -0.15 | -0.12 |
| Free Cash Flow Per Share | 0.04 | 0.15 | 0.13 | -0.15 | -0.14 |
| Dividend Paid and CapEx Coverage Ratio | 1.51 | 4.29 | 6.84 | -32.33 | -0.76 |
| Capital Expenditure Coverage Ratio | 5.97 | 4.29 | 8.48 | -32.33 | -7.08 |
| Operating Cash Flow Coverage Ratio | 0.58 | 1.72 | 0.92 | -0.67 | -0.21 |
| Operating Cash Flow to Sales Ratio | 0.03 | 0.10 | 0.07 | -0.06 | -0.04 |
| Free Cash Flow Yield | 11.14% | 33.21% | 29.92% | -9.13% | -6.83% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 5.50 | 3.37 | 1.99 | 7.44 | -7.56 |
| Price-to-Sales (P/S) Ratio | 0.23 | 0.24 | 0.20 | 0.73 | 0.74 |
| Price-to-Book (P/B) Ratio | 0.24 | 0.27 | 0.28 | 1.28 | 1.93 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.98 | 3.01 | 3.34 | -10.95 | -14.65 |
| Price-to-Operating Cash Flow Ratio | 7.47 | 2.31 | 2.95 | -11.29 | -16.71 |
| Price-to-Earnings Growth (PEG) Ratio | -0.12 | -0.08 | 0.00 | -0.04 | 0.04 |
| Enterprise Value Multiple | -5.41 | -3.88 | -2.81 | 2.01 | -5.93 |
| Enterprise Value | -657.81M | -624.48M | -556.98M | 493.26M | 646.52M |
| EV to EBITDA | -5.41 | -3.88 | -2.81 | 2.01 | -5.93 |
| EV to Sales | -0.54 | -0.46 | -0.36 | 0.30 | 0.33 |
| EV to Free Cash Flow | -20.81 | -5.80 | -5.96 | -4.53 | -6.56 |
| EV to Operating Cash Flow | -17.32 | -4.45 | -5.25 | -4.67 | -7.49 |
| Tangible Book Value Per Share | 1.51 | 1.50 | 1.34 | 1.05 | 0.76 |
| Shareholders’ Equity Per Share | 1.66 | 1.66 | 1.52 | 1.28 | 1.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.33 | 0.22 | 0.23 | 0.18 | -0.13 |
| Revenue Per Share | 1.68 | 1.87 | 2.15 | 2.24 | 2.67 |
| Net Income Per Share | 0.07 | 0.13 | 0.22 | 0.22 | -0.26 |
| Tax Burden | 0.71 | 0.87 | 0.81 | 0.80 | 1.10 |
| Interest Burden | 0.73 | 0.80 | 1.10 | 0.93 | 1.22 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.07 | 0.09 | 0.11 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.76 | 1.27 | 0.54 | -0.53 | 0.50 |
Currency in CNY